← Eichor
Condition: Cutaneous Squamous Cell Carcinoma Cscc Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cutaneous Squamous Cell Carcinoma Cscc

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Cell Carcino
EARLY_Phase 1 · 2 location(s) · Dana-Farber Cancer Institute · NCT06664151Next-gen Flow Cytometry to Find Immune Profiles, Treatment Response, and Toxicity Markers in Skin Cancer Patients Treate
Phase N/A · 1 location(s) · Instituto de Investigación Biomédica de Salamanca · NCT07064330A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
Phase 1/Phase 2 · 20 location(s) · Hummingbird Bioscience · NCT05910827A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients
EARLY_Phase 1 · 2 location(s) · Marissa Lobl · NCT07286318Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT05085496MOHs Surgery and Short-Course Radiation Therapy With Structured Follow-Up for Head & Neck Squamous Cell Skin Cancer
Phase 2 · 1 location(s) · University of Vermont Medical Center · NCT06998342Study of a Strategy Integrating Adjuvant Radiation Therapy Versus Strategy Based on Monitoring in the Treatment of Carci
Phase 3 · 28 location(s) · Centre Leon Berard · NCT06692556Microneedle Array Plus Doxorubicin in Cutaneous Squamous Cell Cancer (cSCC)
Phase 1/Phase 2 · 1 location(s) · Falo, Louis, MD · NCT05377905Towards Cure Via Only Ultra-short ICB in CSCC
Phase 2 · 5 location(s) · The Netherlands Cancer Institute · NCT06823479Pembrolizumab for the Treatment of Locally Advanced and/or Recurrent Orbital or Periocular Cutaneous Squamous Cell Carci
Phase 2 · 1 location(s) · University of Michigan Rogel Cancer Center · NCT06580054Phase 2 Pragmatic Trial of Sentinel Lymph Node Biopsy (SLNB) in Patients With Clinically Node-Negative (cN0), High-Risk
Phase 2 · 1 location(s) · University of California, Davis · NCT06990737ctDNA in Cutaneous Squamous Cell Carcinoma
Phase N/A · 1 location(s) · Massachusetts Eye and Ear Infirmary · NCT06875609A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Phase 1 · 158 location(s) · Seagen, a wholly owned subsidiary of Pfizer · NCT04389632Usefulness of Post-Operative Radiotherapy in High-grade Cutaneous Squamous Cell Carcinoma: an Observational Study
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT06879964A Study of VET3-TGI in Patients With Solid Tumors
Phase 1 · 7 location(s) · KaliVir Immunotherapeutics · NCT06444815Ex Vivo Cutaneous SCC
NA · 1 location(s) · Rigshospitalet, Denmark · NCT07402616A Beta-only IL-2 ImmunoTherapY Study
Phase 1/Phase 2 · 27 location(s) · Medicenna Therapeutics, Inc. · NCT05086692TIL Therapy in cSCC and MCC
Phase 2 · 1 location(s) · Karam Khaddour, MD, MS · NCT07288073Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma
Phase N/A · 1 location(s) · University of California, San Francisco · NCT06606028A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Select
Phase 1 · 2 location(s) · Kupando GmbH · NCT07600476Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
Phase 3 · 52 location(s) · Regeneron Pharmaceuticals · NCT06585410Follow-up of a French National Cohort of Patients With Cutaneous Squamous Cell Carcinoma Requiring Systemic Treatment.
Phase N/A · 29 location(s) · University Hospital, Lille · NCT07606508
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.